Perry L. Scholnick

489 total citations
8 papers, 387 citations indexed

About

Perry L. Scholnick is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Cell Biology. According to data from OpenAlex, Perry L. Scholnick has authored 8 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pediatrics, Perinatology and Child Health and 2 papers in Cell Biology. Recurrent topics in Perry L. Scholnick's work include Porphyrin Metabolism and Disorders (6 papers), Neonatal Health and Biochemistry (5 papers) and Heme Oxygenase-1 and Carbon Monoxide (3 papers). Perry L. Scholnick is often cited by papers focused on Porphyrin Metabolism and Disorders (6 papers), Neonatal Health and Biochemistry (5 papers) and Heme Oxygenase-1 and Carbon Monoxide (3 papers). Perry L. Scholnick collaborates with scholars based in United States. Perry L. Scholnick's co-authors include Harvey S. Marver, Lydia Hammaker, Efraim Racker, Dennis Lang, Rudi Schmid, John H. Epstein, Frank C. Sparks and John S. Hunt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Perry L. Scholnick

7 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Perry L. Scholnick United States 7 318 108 60 54 35 8 387
S. Seubert Germany 9 186 0.6× 85 0.8× 52 0.9× 27 0.5× 19 0.5× 28 378
John D. Vavra United States 5 267 0.8× 64 0.6× 31 0.5× 30 0.6× 11 0.3× 6 558
Harukuni Akita Japan 10 171 0.5× 35 0.3× 15 0.3× 27 0.5× 52 1.5× 15 380
Motoshi Kitamura Japan 11 203 0.6× 20 0.2× 17 0.3× 30 0.6× 55 1.6× 25 374
Elizabeth K. Symes United Kingdom 12 87 0.3× 38 0.4× 75 1.3× 19 0.4× 12 0.3× 20 333
R Michiels Belgium 5 221 0.7× 269 2.5× 46 0.8× 8 0.1× 14 0.4× 8 358
James A. Straw United States 11 87 0.3× 20 0.2× 40 0.7× 57 1.1× 50 1.4× 22 415
Gian Carlo Lunazzi Italy 14 205 0.6× 129 1.2× 25 0.4× 78 1.4× 7 0.2× 23 524
Jerzy Barankiewicz Canada 12 174 0.5× 65 0.6× 19 0.3× 14 0.3× 22 0.6× 25 369
B. M. Tracey United Kingdom 13 384 1.2× 81 0.8× 20 0.3× 71 1.3× 14 0.4× 29 615

Countries citing papers authored by Perry L. Scholnick

Since Specialization
Citations

This map shows the geographic impact of Perry L. Scholnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry L. Scholnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry L. Scholnick more than expected).

Fields of papers citing papers by Perry L. Scholnick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perry L. Scholnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry L. Scholnick. The network helps show where Perry L. Scholnick may publish in the future.

Co-authorship network of co-authors of Perry L. Scholnick

This figure shows the co-authorship network connecting the top 25 collaborators of Perry L. Scholnick. A scholar is included among the top collaborators of Perry L. Scholnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perry L. Scholnick. Perry L. Scholnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Sparks, Frank C., et al.. (1975). Generalized Cutaneous Reaction Associated with the Intratumor Injection of BCG. CHEST Journal. 68(5). 725–727. 13 indexed citations
2.
Scholnick, Perry L.. (1974). Nomenclature of Erythropoietic Protoporphyria-Reply. Archives of Dermatology. 109(4). 575–575.
3.
Scholnick, Perry L., John H. Epstein, & Harvey S. Marver. (1973). The Molecular Basis of the Action of Chloroquine in Porphyria Cutanea Tarda. Journal of Investigative Dermatology. 61(4). 226–232. 78 indexed citations
4.
Scholnick, Perry L., Dennis Lang, & Efraim Racker. (1973). Regulatory Mechanisms in Carbohydrate Metabolism. Journal of Biological Chemistry. 248(14). 5175–5182. 90 indexed citations
5.
Scholnick, Perry L., Lydia Hammaker, & Harvey S. Marver. (1972). Soluble δ-Aminolevulinic Acid Synthetase of Rat Liver. Journal of Biological Chemistry. 247(13). 4132–4137. 41 indexed citations
6.
Scholnick, Perry L., Lydia Hammaker, & Harvey S. Marver. (1972). Soluble δ-Aminolevulinic Acid Synthetase of Rat Liver. Journal of Biological Chemistry. 247(13). 4126–4131. 44 indexed citations
7.
Scholnick, Perry L., Harvey S. Marver, & Rudi Schmid. (1971). Erythropoietic protoporphyria: evidence for multiple sites of excess protoporphyrin formation. Journal of Clinical Investigation. 50(1). 203–207. 82 indexed citations
8.
Scholnick, Perry L., Lydia Hammaker, & Harvey S. Marver. (1969). SOLUBLE HEPATIC δ-AMINOLEVULINIC ACID SYNTHETASE: END-PRODUCT INHIBITION OF THE PARTIALLY PURIFIED ENZYME. Proceedings of the National Academy of Sciences. 63(1). 65–70. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026